The new documentary, produced by Jeb Bush Jr., explores the topic of immigration reform through the lives of undocumented students who win an underwater robotics competition.
The plan would create states with names such as Jefferson, Silicon Valley, South California. The constitutional amendment needs more than 800,000 signatures to qualify; backers say they have enough.
In case you missed it, a customer posted eight minutes of a bleak call with Comcast. His attempt to cancel his cable set a new standard for bad customer service.
Camu camu will soon dethrone açai — an Amazonian berry that's made its mark in the crowded health food market. Or so its promoters are claiming. We asked NPR's Brazil bureau to investigate.
The attack occurred Tuesday morning near a market in the eastern province of Paktika. At a time of political uncertainty, deadly attacks are taking place on a near-daily basis.
First, there was Google Glass. Now, Google is getting into contact lenses, teaming up with the Swiss pharmaceutical company Novartis.
They're working on smart lenses that will be able to monitor blood sugar levels for diabetics through the natural tears in our eyes.
Google and Novartis also say they’re developing another lens that can auto-focus the eye. It could help with reading, because as the eye ages, it’s harder to see things up close.
The two companies complement each other pretty well: Google doesn’t need any money from Novartis, while Novartis can help Google navigate the clinical and regulatory side of things.
“They need more the expertise in terms of running clinical trials, getting approval from the FDA, and then marketing after approval,” says John Mack, who follows the pharmaceutical industry as publisher of "Pharma Marketing News."
Google could definitely use an FDA go-between. About five years ago, the FDA went after pharmaceutical companies about ads that popped up in Google searches. The FDA said the ads didn’t contain relevant risk information.
The partnership also benefits Novartis. Its contact lens division, Alcon, will get a huge jump into smart contact lens technology with the deal.
Novartis sees a lot of potential for contact lenses that monitor our health. The company says it sees the Google deal as an opportunity to “develop and commercialize” Google’s smart lens technology.
CORRECTION: The original version of this story misidentified the publication of John Mack. The text has been corrected.